InsidersTradesSigma
Follow the Apotea share price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Apotea has published 0 public disclosures. Market capitalisation: €7.6bn. The full history is openly available.
Analysts rate Apotea Buy (bullish), based on 2 analysts. Average price target: SEK 92.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Apotea is a Swedish online pharmacy that offers a wide range of health and wellness products. It focuses on convenience and accessibility for its customers.